MENU
+Compare
AWKNF
Stock ticker: OTC
AS OF
Dec 13 closing price
Price
$0.07
Change
-$0.02 (-25.00%)
Capitalization
2.77M

AWKNF Awakn Life Sciences Corp. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
AWKNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for AWKNF with price predictions
Dec 17, 2024

AWKNF's Stochastic Oscillator is sitting in oversold zone for 17 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

AWKNF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 25, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on AWKNF as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AWKNF turned negative on November 21, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

AWKNF moved below its 50-day moving average on December 02, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AWKNF crossed bearishly below the 50-day moving average on December 09, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AWKNF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AWKNF entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). AWKNF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (39.841) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AWKNF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AWKNF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
AWKNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
301‐217 Queen Street West
Phone
+1 416 361-2517
Employees
43
Web
https://www.awaknlifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSCYX18.73N/A
N/A
GuideStone Funds Small Cap Equity Instl
RCLIX42.00-0.18
-0.43%
T. Rowe Price US Large-Cap Core I
NBGUX29.25-0.15
-0.51%
Neuberger Berman Large Cap Growth Adv
HSXFX8.68-0.07
-0.80%
Hartford Schroders Diversified Em Mkts F
THIGX37.70-0.54
-1.41%
Thornburg Small/Mid Cap Growth I

AWKNF and Stocks

Correlation & Price change

A.I.dvisor tells us that AWKNF and IVEVF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AWKNF and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AWKNF
1D Price
Change %
AWKNF100%
N/A
IVEVF - AWKNF
25%
Poorly correlated
N/A
MBCOF - AWKNF
20%
Poorly correlated
N/A
SYGGF - AWKNF
15%
Poorly correlated
N/A
ASPHF - AWKNF
10%
Poorly correlated
N/A
PYXS - AWKNF
7%
Poorly correlated
-2.98%
More